ZEGERID (OMEPRAZOLE; SODIUM BICARBONATE) — FDA Approval NDA021636 (SALIX)
ZEGERID (OMEPRAZOLE; SODIUM BICARBONATE) — FDA Approval NDA021636 (SALIX) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ZEGERID; Active ingredients: OMEPRAZOLE; SODIUM BICARBONATE; Application number: NDA021636.
| Brand name | ZEGERID |
|---|---|
| Active ingredients | OMEPRAZOLE; SODIUM BICARBONATE |
| Application number | NDA021636 |
| Sponsor | SALIX |
| Dosage form | FOR SUSPENSION |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20040615 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →